secwatch.observer — SEC 8-K summary
======================================

Issuer:     PIPER SANDLER COMPANIES (PIPR)
CIK:        0001230245
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001230245-26-000005
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Piper Sandler elects Stuart M. Essig to board, effective Feb 4, 2026
--------------------------------------------------------------------

- Essig was CEO of Integra LifeSciences (1997-2012), growing revenue from ~$15M to $1.6B.
- Board expands to 10 directors; Essig appointed to Audit Committee.
- Compensation: pro-rated $100K cash retainer, $60K initial equity, $150K annual equity after 2026 meeting.
- Essig also serves on IDEXX Laboratories board; previously healthcare M&A banker at Goldman Sachs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/0001230245-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/pipr-20260204.htm
  HTML page:      https://secwatch.observer/filing/0001230245-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer